Yatsen turns to AI and biotech as demand grows for targeted beauty products
The company is using technology for things like new ingredient discovery as Chinese consumers seek increasingly…
China’s hepatitis B drug race enters critical phase as Cosunter commits 587 million yuan
The Chinese drugmaker is stepping up investment in its hepatitis B pipeline as GSK’s bepirovirsen wins regulatory…
From designing molecules to making medicines: AI drug discovery enters its next phase
AI is moving from lab novelty to clinical reality. The next test is whether faster molecule…
A $137,000 cancer shot brings foreign patients to China
China is attracting foreign patients with faster treatment, lower costs and access to therapies unavailable in…
Concealed death of child in China gene-editing trial sparks probe and scientific integrity concerns
The unauthorized trial of a customized base-editing treatment on a six-year-old girl exposes severe compliance gaps…
China hits brain-computer interface milestone, but success masks steep commercial and financial hurdles
Despite a landmark implant, China’s brain-computer interface startups face grueling rehabilitation realities and prohibitive out-of-pocket costs…
China adds 67 unicorns in first half as artificial intelligence and robotics drive startup rebound
A surge in AI and robotics startups has lifted China’s unicorn creation to its strongest half-year…
Biokin’s new cancer drug secures historic approval in China, but Western regulatory hurdles loom
Backed by an $8.4 billion international licensing deal with Bristol Myers Squibb, Biokin’s groundbreaking dual-target therapy…
Early Shanghai trial data points to promise for therapeutic mRNA cancer vaccines
By Da Cheung The American Society of Clinical Oncology (ASCO) annual meeting, which concluded on June…
Beyond Neuralink: China’s BCI industry shatters funding records as government backs brain-computer interfaces
By Da Cheung Chinese companies developing brain-computer interface (BCI) systems are witnessing a surge in fundraising this…
Latest
- After forced Meta split, AI startup Manus regroups with new $500 million funding
- China’s maturing energy storage sector creates giants, leaves behind trail of bankruptcies
- A Guangzhou factory bet big on robots. Its customers only wanted them to carry more.
- China’s satellite IoT bet: small data, big business
- Tactile sensor maker Tashan targets IPO after completing share reform
